Paragon Therapeutics, Inc. — Form D

Paragon Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-10. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-05-10
• Form: D
• Accession: 0000897069-21-000219
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $10.0M
• Investors: 2
• Date of first sale: 2021-04-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-398700

Issuer

• Name: Paragon Therapeutics, Inc.
• CIK: 0001861055
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: C/O FAIRMOUNT FUNDS MANAGEMENT, LLC, PHILADELPHIA, PA, 19103
• Phone: (267) 760-4066

Officers, directors & promoters (4)

More

• CIK 1861055 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search